|Chemical and physical data|
|Molar mass||378.47 g/mol g·mol−1|
|3D model (JSmol)|
CSP-2503 is a potent and selective 5-HT1A receptor agonist, 5-HT2A receptor antagonist, and 5-HT3 receptor antagonist of the phenylpiperazine class. First synthesized in 2003, it was designed based on computational models and QSAR studies. In rat studies, CSP-2503 has demonstrated anxiolytic effects, and thus has been suggested as a treatment for anxiety in humans with a multimodal mechanism of action.
(α2δ VDCC blockers)
(no additional rings)
(piperazine attached via side chain)